In his first 6 months as HHS secretary, Robert F. Kennedy Jr. has looked on as the FDA approved three mRNA-based vaccines: ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

By Hope Hamilton To Southampton Arts Center Executive Director Christina Mossaides-Strassfield, Christine Mack is a “modern-day Medici” — an art collector who emphasizes, recognizes and uplifts the ...

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Dash's Fully Automated Bioanalysis Platform Is Reshaping Drug Development with Speed, Precision, and Scale. NEWTON, Mass., ...

The company seeks to accelerate drug development by automating analysis of study samples.

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Laboratorios Rovi (ROVI) will publish its Q2 2025 results on Thursday 24 July at 10 a.m. We expect some improvement on the ...

Sanofi is buying U.K. biotechnology company Vicebio for up to $1.6 billion in a deal that seeks to strengthen the French drugmaker's portfolio of respiratory vaccines and leave pipeline setbacks ...

The deal adds vaccine candidates for respiratory syncytial virus and human metapneumovirus to the French pharmaceutical group ...